• Profile
Close

Cost-effectiveness and cost-utility of population-based glaucoma screening in China: A decision-analytic Markov model

The Lancet Global Health Jun 17, 2019

Tang J, et al. - Via a cohort study of individuals from age 50 years through a total of 30 1-year decision-analytic Markov models, the researchers intended to assess the cost-effectiveness and cost-utility of population-level glaucoma screening in China. Fewer net costs and greater gain in health benefits in comparison to no screening for glaucoma [primary open angle glaucoma and primary angle closure glaucoma (PACG)] combined were predicted for the rural as well as urban China setting. Cost effectiveness of particularly labor costs, and the high risk of blindness in untreated cases and in those with PACG were observed.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay